Independent · Reader-Supported · Editorially Reviewed
§ Brand Review · Longevity & NAD+

Enhance.MD Review

Provider-led metabolic and NAD+ wellness platform with transparent flat pricing.

Last reviewed July 2026
4 studies cited
Fact-checked 18 July 2026Last updated 15 June 2026From $149 – $399/moEditor Score 4.0 / 5Trustpilot 4.1 · Great

Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology

Quick Verdict

Provider-led metabolic and NAD+ wellness platform with transparent flat pricing.

Who it's for: Best fit for readers who want NAD+ therapy without committing to a hardcore longevity clinic. The dual injection-or-wafer choice gives flexibility for needle-averse buyers. It is not a full-service GLP-1 clinic, so buyers who primarily want weight-loss medication should look at a dedicated GLP-1 platform instead.

Bottom line: A specialist NAD+ option with a metabolic side gig. Reasonable entry price; just don't expect the breadth of a multi-category clinic. The NAD+ focus is the clearest differentiator; if you want a multi-category men's health platform with ED and TRT alongside NAD+, compare EnhanceMD against System Labs on total monthly cost.

Pros
  • Specialised NAD+ menu with both injection and wafer formats
  • Low monthly entry price
  • Transparent flat pricing, no dose surcharges
Cons
  • Narrow product range. limited beyond NAD+ and GLP-1
  • Less established brand recognition than category leaders

Pros & Cons In Detail

Specialised NAD+ menu with both injection and wafer formats
In practice this is one of the differentiators that pushes Enhance.MD's editor score above the category median.
Low monthly entry price
In practice this is one of the differentiators that pushes Enhance.MD's editor score above the category median.
Transparent flat pricing, no dose surcharges
That matters because GLP-1 dosing typically titrates upward over the first six months. programs that surcharge by dose can quietly double a monthly bill that started low.
Narrow product range. limited beyond NAD+ and GLP-1
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.
Less established brand recognition than category leaders
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.

Enhance.MD Pricing

Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at Enhance.MD.

Program / Membership FeeFrom $49/mo
Medication Cost (From)From $149 – $399/mo
What This Means For You

Enhance.MD uses transparent flat pricing, the monthly subscription includes provider oversight and the chosen medication. NAD+ wafers and injectables are listed at flat in-cart prices.

Who Enhance.MD Is For

Best fit for readers who want NAD+ therapy without committing to a hardcore longevity clinic. The dual injection-or-wafer choice gives flexibility for needle-averse buyers. It is not a full-service GLP-1 clinic, so buyers who primarily want weight-loss medication should look at a dedicated GLP-1 platform instead.

How Enhance.MD Markets Itself

Adults who want a low-friction entry into NAD+ therapy alongside metabolic care.

Signature Programs

  • ›NAD+ injections
  • ›NAD+ wafers (sublingual)
  • ›Compounded GLP-1 with metabolic coaching

Medication Formulary

Full Formulary
compounded semaglutidecompounded tirzepatidenad+ injectionsnad+ wafers

The Bottom Line

A specialist NAD+ option with a metabolic side gig. Reasonable entry price; just don't expect the breadth of a multi-category clinic. The NAD+ focus is the clearest differentiator; if you want a multi-category men's health platform with ED and TRT alongside NAD+, compare EnhanceMD against System Labs on total monthly cost.

With an editor score of 4.0 / 5 across cost, experience, and trust, Enhance.MD is one of the specialty options in the longevity & nad+ category we cover.

See how Enhance.MD compares in our full longevity & nad+ rankings, or read the Best Telehealth GLP-1 Providers guide. Our methodology explains how we score each provider.

§ FAQ

Frequently Asked Questions

References
  1. Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
  2. FDA Federal Register 2024 (Semaglutide shortage end) · FDA removed semaglutide from the drug shortage list in October 2024, ending the legal basis for compounding.
  3. Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss vs 3.1% placebo at 72 weeks in SURMOUNT-1.
  4. FDA Federal Register 2024 (Tirzepatide shortage end) · FDA removed tirzepatide from the drug shortage list in October 2024.

RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.

§ Readers Also Compared

How Enhance.MD Stacks Up

Alternatives To Enhance.MD

§ Continue Reading